RecruitingBurnsSkin Graft Complications
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Investigators hypothesize that topical tranexamic acid will have better or comparable efficacy to topical thrombin in reducing hematoma formation at the wound base. The purpose of the study is to demonstrate that topical tranexamic acid will be a non-inferior alternative medication to the current standard of care,THROMBIN-JMI® , and at a lower cost to the health system.
Sponsor: University of Kansas Medical Center
You may qualify if…
- ✓ English or Spanish speaking
- ✓ Flame or scald burn injury
- ✓ \<=10% total body surface area (TBSA) partial thickness
- ✓ \<= 5% total body surface area (TBSA) deep partial or full thickness
- ✓ Skin graft harvested at 1/12 inch depth, meshed 1:1 or pie crusted if the area is a small functional area
You may not qualify if…
- ✕ \>10% total body surface area (TBSA) partial thickness burn
- ✕ \>5% total body surface area (TBSA )surgical area of burn injury (deep partial or full thickness injury)
- ✕ Traumatic or chemical burn mechanism
- ✕ Patients on immunosuppression
- ✕ Uncontrolled diabetes
- ✕ Known diagnosis of peripheral vascular disease or diagnosis at time of injury
- ✕ Pregnant women
- ✕ Patients with acquired defective color vision
Where it's recruiting
Kansas
Kansas City
Source: ClinicalTrials.gov · NCT06379724 · last updated 2026-08-27